Cigna officially offloads its Medicare Advantage business to Health Care Service Corporation. The Biden Administration will negotiate on behalf of states to provide a groundbreaking gene therapy for Medicaid beneficiaries with sickle cell disease. And, the Dana Farber Cancer Institute is issuing corrections and retracting some research papers amid falsification allegations. That’s coming up on today’s episode of Gist Healthcare Daily.
Hosted on Acast. See acast.com/privacy for more information.
